Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy
NCT03961087Unknown
- Sponsor
- Zagazig University
- Start
- May 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of coenzyme q10 and meclofenoxate in hepatic encephalopathy (HE) (2 arms), sponsored by Zagazig University. Primary endpoints: Hepatic Encephalopathy Frequency and Severity at 6 months, Health Related Quality of Life at 6 months and 1 more. Status: unknown.
02
Drugs
coenzyme q10meclofenoxate
03
Conditions
hepatic encephalopathy (HE)
Beyond the preview
Go deeper on NCT03961087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03961087.